MediXall (MDXL) Equity Ratio (2019 - 2024)
MediXall's Equity Ratio history spans 8 years, with the latest figure at 16.45 for Q3 2024.
- For Q3 2024, Equity Ratio fell 42.76% year-over-year to 16.45; the TTM value through Sep 2024 reached 16.45, down 42.76%, while the annual FY2023 figure was 32.44, 662.06% down from the prior year.
- Equity Ratio reached 16.45 in Q3 2024 per MDXL's latest filing, up from 32.69 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.43 in Q1 2021 to a low of 32.69 in Q2 2024.
- Average Equity Ratio over 5 years is 9.01, with a median of 3.56 recorded in 2022.
- Peak YoY movement for Equity Ratio: plummeted 4492.59% in 2022, then tumbled 42.76% in 2024.
- A 5-year view of Equity Ratio shows it stood at 0.23 in 2020, then tumbled by 229.35% to 0.3 in 2021, then crashed by 1316.21% to 4.26 in 2022, then crashed by 662.06% to 32.44 in 2023, then surged by 49.29% to 16.45 in 2024.
- Per Business Quant, the three most recent readings for MDXL's Equity Ratio are 16.45 (Q3 2024), 32.69 (Q2 2024), and 25.8 (Q1 2024).